Pharmaceutical serialization dynamics to restrain illicit trade and counterfeiting of drugs
Maryland, USA.
Review Article
World Journal of Advanced Research and Reviews, 2024, 22(02), 913–918
Article DOI: 10.30574/wjarr.2024.22.2.1461
Publication history:
Received on 02 April 2024; revised on 12 May 2024; accepted on 14 May 2024
Abstract:
Every individual has a fundamental entitlement to healthcare access. It falls upon governments to guarantee the delivery of high-quality healthcare services and infrastructure to their populace.. Over the past few decades, both governments and healthcare industries have been grappling with the challenge of minimizing the adverse effects on public health caused by counterfeit medicines. The World Health Organization has estimated that 40 % medicines in developing and impoverished countries are either counterfeit or potentially adulterated. The global economy suffers billions of dollars in losses due to counterfeit drugs, which also divert funds away from research and development (R&D) initiatives.
In the United States, the Food and Drug Administration (FDA) has devised a 10-year roadmap to implement drug traceability measures. The Healthcare Distribution Alliance (HDA) has been tasked with mandating the printing of multiple barcodes and human-readable data on product packaging. Additionally, the FDA is actively involved in pilot projects with leading pharmaceutical manufacturers and wholesalers to leverage blockchain technology within interoperable digital networks for secure data transfer and traceability among authorized trading partners.
Preventing counterfeit medicines from infiltrating the supply chain remains a significant challenge for governments and regulatory authorities. Consequently, there is a growing emphasis on implementing stringent guidelines to deter criminals and counterfeiters from distributing fake medicines in the market. The healthcare industry requires robust regulations and secure technologies to ensure the delivery of safe and authentic drugs to patients.
Keywords:
Pharmaceutical Supply Chain; Drug Traceability; Drug Counterfeit; Pharmaceutical Serialization; Track and Trace System; Enterprise System; Blockchain; IoT
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0